解开非化STAT3-非化NF-κB通路在功能丧失中的STAT3超IgE综合征
Adil Karim1, Rashi Garg1, Biman Saikia1
1Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Frontiers in immunology
|September 4, 2024
概括
与转录3相关的超IgE综合征 (LOF STAT3 HIES) 的信号传感器和激活器功能丧失涉及非正规STAT3信号的受损. 这项研究揭示了减少RANTES和STAT3的表达,突出了它们在HIES病原发生中的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 与转录3相关的超IgE综合征 (LOF STAT3 HIES) 的信号传感器和激活器功能丧失的特征是复发性感染和升高的IgE.
- 缺陷的STAT3信号会通过正规的JAK-STAT通路损害Th17细胞的反应.
- 非正规的非化STAT3通路在HIES病变发生过程中的作用仍然在很大程度上未被探索.
研究的目的:
- 在LOF STAT3 HIES患者中调查非化STAT3-非化NF-κB (uSTAT3-uNF-κB) 激活途径的参与.
- 探索非正规STAT3途径对高IgE综合征的贡献.
主要方法:
- 在五名LOF STAT3 HIES患者和STAT3突变体中评估了uSAT3-uNF-κB途径下游分子的mRNA表达.
- 用IL-6刺激细胞和分析下游信号分子.
- 使用免疫沉试验来评估STAT3和NF-κB与RANTES促进体的结合.
主要成果:
- 在LOF STAT3 HIES患者和STAT3突变者中观察到关键下游分子的mRNA表达减少,包括RANTES,STAT3,IL-6和IL-8.
- 免疫沉研究表明,在HIES患者中,STAT3,NF-κB和RANTES促进剂之间的相互作用减少.
- 在RANTES和STAT3表达的特定降低证实了usTAT3-uNF-κB通路的损害.
结论:
- 这些发现证实了STAT3 LOF HIES中 uSTAT3-uNF-κB通路受损,证据是下游分子如RANTES和STAT3.3的表达减少.
- 减少RANTES和STAT3的水平是导致超IgE综合征的致病的重要因素.
- 这项研究阐明了非正典STAT3途径在HIES中的作用,为进一步的研究和潜在的治疗点开辟了道路.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K


